Ultragenyx Pharmaceutical (RARE) Non-cash Items (2013 - 2017)

Ultragenyx Pharmaceutical (RARE) has 5 years of Non-cash Items data on file, last reported at $2.7 million in Q4 2017.

• Non-cash Items for Q4 2017 came in at $2.7 million, down 96.58% year-over-year; the trailing twelve-month figure through Dec 2017 was $2.7 million (down 96.58% YoY), and the FY2017 annual result was $2.7 million, down 96.58% from the prior year.
• Non-cash Items retreated to $2.7 million in Q4 2017 per RARE's latest filing, from $79.1 million in the prior quarter.
• Over five years, Non-cash Items peaked at $217.4 million in Q4 2015 and troughed at $2.7 million in Q4 2017.
• A 5-year average of $79.7 million and a median of $79.1 million in 2016 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2014 and 2017: Non-cash Items jumped 310.11% in 2014, then plunged 96.58% in 2017.
• A 5-year view of Non-cash Items shows it stood at $19.5 million in 2013, then soared by 310.11% to $79.8 million in 2014, then surged by 172.28% to $217.4 million in 2015, then sank by 63.6% to $79.1 million in 2016, then sank by 96.58% to $2.7 million in 2017.
• Business Quant data shows RARE's Non-cash Items at $2.7 million in Q4 2017, $79.1 million in Q4 2016, and $217.4 million in Q4 2015.